---
schema_version: "secwatch.filing_event.v1"
accession: "0001387131-23-004783"
form_type: "8-K"
ticker: null
cik: "0000887247"
company_name: "DMK PHARMACEUTICALS Corp"
filed_at: "2023-04-17T23:59:59+00:00"
generated_at: "2026-06-17T01:42:14.966436+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Adamis Pharmaceuticals receives Nasdaq deficiency notice for MVLS below $35M

## Summary
- Nasdaq notice on April 12, 2023: Market Value of Listed Securities below $35M for 30 consecutive business days.
- Company has until Oct 9, 2023 to regain compliance by achieving MVLS >= $35M for 10 consecutive business days.
- If not compliant by deadline, Nasdaq will issue delisting notice; company may appeal.
- No immediate impact on listing or trading of common stock (ADMP).

## SEC filing metadata
- accession: 0001387131-23-004783
- form_type: 8-K
- cik: 0000887247
- company_name: DMK PHARMACEUTICALS Corp
- filed_at: 2023-04-17T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/887247/000138713123004783/0001387131-23-004783-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/887247/000138713123004783/admp-8k_041223.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001387131-23-004783
- JSON: https://secwatch.observer/filing/0001387131-23-004783.json
- Plain text: https://secwatch.observer/filing/0001387131-23-004783.txt

## Key facts
- Listing & Compliance Notices
  DMK PHARMACEUTICALS Corp received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: market value
  - Rules: 5550(b)(2)
  source text: April 12, 2023, Adamis Pharmaceuticals Corporation (“Adamis” or the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that for the last 30 consecutive business days, the Company’s minimum Market Value of Listed Securities (“MVLS”) was below the minimum of $35 million required for continued listing on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(b)(2) (the “Market Value Standard”). The Notice is only a notification of deficiency, not of imminent delisting
  evidence_url: https://www.sec.gov/Archives/edgar/data/887247/000138713123004783/0001387131-23-004783-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.